orphan disease
Market Access/ News/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis
Balancing expectations: An unmet need in the orphan disease arena
mike.hammerton@pharmaphorum.com
OMP, orphan disease, orphan medicinal products, rare disease
0 Comment
Partner Content/ Partner Content/ Patients/ R&D
Hear from HealthTech Healx which raised $10m to accelerate drug discovery
Adam Jeffery
AI, Healx, orphan disease, Orphan drug, SMi Group
0 Comment
FDA approves Teva’s Huntington’s Disease drug
Richard Staines
fda, Huntington's disease, neurology, orphan disease, Teva
0 Comment
First treatment approved for Huntington’s Disease in almost a decade.
Funding rare disease treatments in the UK – navigating the labyrinth
Claire
Highly Specialised Technology, orphan disease, patients, rare disease
0 Comment